Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): "The APA Trial".

NCT02573493 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02573493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02573493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): "The APA Trial".
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
April 13, 2016
Completion date
July 1, 2024
Enrollment
96 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of head and neck, cancer of the head and neck, carcinoma, squamous cell of the head and neck, head and neck cancer, neoplasms, head and neck, squamous cell carcinoma of the head and neck